CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5501.60161.6 (+3.03 %)
PREV CLOSE () 5340.00
OPEN PRICE () 5340.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25104
TODAY'S LOW / HIGH ()5310.35 5501.60
52 WK LOW / HIGH ()5052.05 5933
NSE5466.50118 (+2.21 %)
PREV CLOSE() 5348.50
OPEN PRICE () 5378.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5466.50 (651)
VOLUME 320770
TODAY'S LOW / HIGH() 5310.50 5466.50
52 WK LOW / HIGH ()5051 5933.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1973

Management Info :

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office :

Address : Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone : 022 3982 9999

Website : www.alkemlabs.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
16Sep Alkem Laboratories launches NeuCeno fo
Alkem Laboratories has launched NeuCeno (cenobamate), anti-seizure medic..
16Sep Alkem Laboratories informs about press
Alkem Laboratories has informed that the Company today announced the lau..
16Sep Alkem Laboratories inches up on launch
Alkem Laboratories is currently trading at Rs. 5159.50, up by 4.50 point..
08Sep Alkem Laboratories launches Ginsenosid
Alkem Laboratories has launched Renocia Exo, a next-generation hair rege..
16Jul Alkem Laboratories informs about acqui
Alkem Laboratories has informed that the Company has acquired 79,36,50,7..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit5699.822820.9
Gross Profit 7984.2 25226.2
Operating Profit 8731.629795.6
Net Sales 26677.396639.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27273.30 (5.26%)
M.Cap ( in Cr)
57953.86
Neuland Laboratories (BSE)
 22875.70 (0.97%)
M.Cap ( in Cr)
29349.27
Caplin Point Labs. (BSE)
 2747.85 (5.87%)
M.Cap ( in Cr)
20886.87
Acutaas Chemicals (BSE)
 3438.15 (3.70%)
M.Cap ( in Cr)
28148.52
Emcure Pharma (BSE)
 2015.75 (5.53%)
M.Cap ( in Cr)
38240.92
Shareholding Pattern
PROMOTERS 49.7%
NON-INSTITUTION 17.25%
MUTUAL FUNDS/UTI 16.71%
FI/BANKS/INSURANCE 4.17%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74294.96-19.63 (-0.03%)
NIFTY23346.4075.80 (0.33%)
Dow Jones 51682.64-95.40 (-0.18%)
Nasdaq 26522.54104.24 (0.39%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI